KERRIANN WELCH: Open Payments
NPI 1235604281 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 55 payments from 17 companies in 2025. Trend: 2023 $1,319 · 2024 $917 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $239 |
| Janssen Biotech, Inc. | 10 | $210 |
| UCB, Inc. | 5 | $135 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $132 |
| LEO Pharma Inc. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Galderma Laboratories, L.P. | 3 | $64 |
| GENZYME CORPORATION | 2 | $57 |
| Amgen Inc. | 2 | $48 |
| Lilly USA, LLC | 1 | $33 |
Products named: TREMFYA, RINVOQ, Bimzelx, Cabtreo, ADBRY, SKYRIZI, NEMLUVIO, DUPIXENT.
Industry payments across CT — which companies pay providers there.
